Showing results (31-40 of 41) with videos related to
Sort By:
Pageof 5
The Journal of Physiology|March 19, 2016
Mechano-signalling pathways in an experimental intensive critical illness myopathy modelRebeca Corpeno Kalamgi, Heba Salah, Stefano Gastaldello, et al.Annals of the Rheumatic Diseases|March 18, 2026
Inhibition of the type I interferon receptor pathway protects against muscle weakness induced by dermatomyositis serumSuchada Kaewin, Cecilia Leijding, Stefano Gastaldello, et al.Antioxidants (Basel, Switzerland)|September 28, 2021
Vitamin C and E Treatment Blocks Changes in Kynurenine Metabolism Triggered by Three Weeks of Sprint Interval Training in Recreationally Active Elderly HumansVictoria L Wyckelsma, Ada Trepci, Lilly Schwieler, et al.Cancer Letters|February 21, 2021
Caveolin-1 promotes radioresistance in rhabdomyosarcoma through increased oxidative stress protection and DNA repairSilvia Codenotti, Francesco Marampon, Luca Triggiani, et al.Journal of Autoimmunity|January 10, 2026
Sera from patients with dermatomyositis and antisynthetase syndrome mediate muscle weakness, impair mitochondrial respiration and induce local cytokine production in muscle tissueCecilia Leijding, Stefano Gastaldello, Tomas Schiffer, et al.Cancers|March 13, 2024
Statin-Sensitive Akt1/Src/Caveolin-1 Signaling Enhances Oxidative Stress Resistance in RhabdomyosarcomaSilvia Codenotti, Leonardo Sandrini, Delia Mandracchia, et al.Science Translational Medicine|August 5, 2016
The chaperone co-inducer BGP-15 alleviates ventilation-induced diaphragm dysfunctionHeba Salah, Meishan Li, Nicola Cacciani, et al.Antioxidants (Basel, Switzerland)|September 22, 2020
Vitamin C and E Treatment Blunts Sprint Interval Training-Induced Changes in Inflammatory Mediator-, Calcium-, and Mitochondria-Related Signaling in Recreationally Active Elderly HumansVictoria L Wyckelsma, Tomas Venckunas, Marius Brazaitis, et al.Cells|September 23, 2022
Hyperactive Akt1 Signaling Increases Tumor Progression and DNA Repair in Embryonal Rhabdomyosarcoma RD Line and Confers Susceptibility to Glycolysis and Mevalonate Pathway InhibitorsSilvia Codenotti, Daniela Zizioli, Luca Mignani, et al.Science Translational Medicine|July 22, 2021
Toward predicting CYP2D6-mediated variable drug response from <i>CYP2D6</i> gene sequencing dataMaaike van der Lee, William G Allard, Rolf H A M Vossen, et al.Pageof 5